South Africa Seeks New Vaccine Strategy After Study

A vaccine is being put on hold after a study found it offers minimal protection against mild and moderate cases of a variant first discovered in South Africa. Severe cases were not included in the study. The company is collaborating with South African leaders to determine the next steps. Meanwhile, South Africa is proceeding with Johnson and Johnson and Pfizer vaccines.

What new insight or understanding did you gain from this video?